The EMPEROR trial showed that within 30 days of stopping empagliflozin, patients had a 70% higher risk of heart failure events, explained Milton Packer, MD, Baylor University Medical Center.
The latest findings from the EMPEROR trial were presented at the European Society of Cardiology (ESC) Congress 2023 and focused the effects of empagliflozin discontinuation. According to Milton Packer, MD, of Baylor University Medical Center in Dallas, Texas, these findings demonstrate that the benefit of sodium glucose co-transporter 2 (SGLT2) inhibitors disappears within 30 days after patients stop taking the drug.
Transcript
What are the latest updates on the EMPEROR trial being presented at ESC Congress 2023?
The most exciting results we presented at this meeting on the EMPEROR trial was the withdrawal of empagliflozin in 7000 patients—7000 patients who had survived to the end of the trial, half on placebo half on empagliflozin, and they were blindly withdrawn for 30 days. No one had ever done this before. No one had ever done this with any foundational drug before. We give foundational drugs forever, for years, and we don't know whether they keep working or not. The only way to know if they work or not is to take them away and see if patients can continue to be stable or get worse.
When we withdrew people from placebo, they remained completely stable, as you would expect—we were taking away placebo. When we took away empagliflozin, there was a 70% increase in heart failure events, there was worsening of symptoms, worsening of health status, and all of the renal tubular effects of SGLT2 inhibitors reversed. All the biochemical changes, laboratory changes, [and] physical signs all reversed, and they were the mirror image of what we saw at the very beginning of the trial.
So, the conclusions that we reached is empagliflozin persists for years. It produces its benefits, which continue for as long as the patient takes the drug. But, if the patient stops taking the drug, they're going to get worse within 30 days. We thought that was extraordinary.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
2 Commerce Drive
Cranbury, NJ 08512